HARROWCatch this wave 3. I think we are almost finished wave 2 wich is mostly the most extreme. So now i expect the wave 3 is going to start.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.95 USD
−24.41 M USD
130.19 M USD
30.34 M
About Harrow, Inc.
Sector
CEO
Mark L. Baum
Headquarters
Nashville
Website
Founded
2006
FIGI
BBG000QXWY44
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
HROW: Can you guess what this pattern is called?See if you can guess it correctly. Earnings on 11/13
Eye Spy a MultibaggerI was hesitant to publish this chart because the extreme upside it shows will likely be viewed as unrealistic. However, HROW recently decisively broke above its 4-year trend channel as business developments have been quite positive lately - particularly with IHEEZO. This is a rare setup where the fu
HROW: Eye Spy A BottomHROW with a nice impulsive, 5-wave move off the low. HROW needs to hold the 0.618 retracement ($18.75) on this pull back, followed by a rally above the $19.95 local peak set today for further confirmation. Very bullish on the long-term prospects of this ticker.
HROW pull back - thoughts?Bounce off of 100 SMA, 2 long bullish candles with lots of volume, plus sound fundamentals. Any thoughts?
HROW - Long Setup Flag Setup with 2020 Insider Buying. Possible entry here or above 8.44., Stop signal 7.83, First target 9.23. 2nd Target Momentum.
Short Term Rise before head and shoulders completion?I see a short term rise in HROW as our current right shoulder of what looks to be a weekly head and shoulders hit a 61.8% Fibonacci retracement level with Stochastic RSI being as oversold as our last oversold areas. I drew two potential rises using some bear rally based Fibonacci Retracments, I feel
Harrow may bounce on lawsuit newsBack in May, a jury ruled in Harrow Health's favor in a lawsuit that Allergan filed against Harrow for intellectual property infringement. Allergan has been appealing the ruling, but today the two companies jointly filed an 8k form indicating that they had jointly dismissed all pending appeals and e
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HROW is 52.51 USD — it has increased by 5.21% in the past 24 hours. Watch Harrow, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Harrow, Inc. stocks are traded under the ticker HROW.
HROW stock has risen by 15.53% compared to the previous week, the month change is a 3.82% rise, over the last year Harrow, Inc. has showed a 300.84% increase.
We've gathered analysts' opinions on Harrow, Inc. future price: according to them, HROW price has a max estimate of 73.00 USD and a min estimate of 44.80 USD. Watch HROW chart and read a more detailed Harrow, Inc. stock forecast: see what analysts think of Harrow, Inc. and suggest that you do with its stocks.
HROW reached its all-time high on Oct 6, 2009 with the price of 160.00 USD, and its all-time low was 0.50 USD and was reached on Mar 16, 2012. View more price dynamics on HROW chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HROW stock is 6.68% volatile and has beta coefficient of 2.11. Track Harrow, Inc. stock price on the chart and check out the list of the most volatile stocks — is Harrow, Inc. there?
Today Harrow, Inc. has the market capitalization of 1.86 B, it has decreased by −16.25% over the last week.
Yes, you can track Harrow, Inc. financials in yearly and quarterly reports right on TradingView.
Harrow, Inc. is going to release the next earnings report on Nov 13, 2024. Keep track of upcoming events with our Earnings Calendar.
HROW earnings for the last quarter are −0.18 USD per share, whereas the estimation was −0.18 USD resulting in a 1.82% surprise. The estimated earnings for the next quarter are −0.05 USD per share. See more details about Harrow, Inc. earnings.
Harrow, Inc. revenue for the last quarter amounts to 48.90 M USD, despite the estimated figure of 42.51 M USD. In the next quarter, revenue is expected to reach 52.80 M USD.
HROW net income for the last quarter is −6.47 M USD, while the quarter before that showed −13.56 M USD of net income which accounts for 52.28% change. Track more Harrow, Inc. financial stats to get the full picture.
No, HROW doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 9, 2024, the company has 315.00 employees. See our rating of the largest employees — is Harrow, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Harrow, Inc. EBITDA is 4.29 M USD, and current EBITDA margin is 9.92%. See more stats in Harrow, Inc. financial statements.
Like other stocks, HROW shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Harrow, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Harrow, Inc. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Harrow, Inc. stock shows the buy signal. See more of Harrow, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.